Cardiovascular Risk Evaluation through Heart Rate Variability (HRV) Analysis in Patients with Psoriasis before and after 12 Weeks of Etanercept Therapy: A Preliminary Prospective Study
Conclusion Our data suggest that treatment with etanercept in patients with moderate-to-severe psoriasis doesn ' t affect cardiovascular autonomic regulation, and subsequently the cardiovascular risk.
Source: Acta Dermatovenerologica Croatica - Category: Dermatology Source Type: research
More News: Cardiology | Cardiovascular | Dermatology | Enbrel | Epidemiology | Heart | Psoriasis | Reflex Sympathetic Dystrophy | Study